Institute of Translational & Precision Medicine, Nantong University, Nantong, JS 226001, China; School of Medicine, Shanghai University, Shanghai 200444, China.
School of Biomedical Sciences and Gerald Choa Neuroscience Centre, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, NT, Hong Kong.
Trends Endocrinol Metab. 2023 Jul;34(7):404-413. doi: 10.1016/j.tem.2023.04.003. Epub 2023 May 18.
Despite several decades of study, whether iron is involved in the development of atherosclerosis remains a controversial and unresolved issue. Here, we focus on the up-to-date advances in studies on role of iron in atherosclerosis and discuss possible reasons why patients with hereditary hemochromatosis (HH) do not show any increased incidence of atherosclerosis. In addition, we analyze conflicting results concerning the role of iron in atherogenesis from several epidemiological and animal studies. We argue that atherosclerosis is not observed in HH because iron homeostasis in the arterial wall, the actual location of atherosclerosis, is not significantly affected, and support a causal link between iron in the arterial wall and atherosclerosis.
尽管经过了几十年的研究,铁是否参与动脉粥样硬化的发展仍然是一个有争议且尚未解决的问题。在这里,我们重点介绍铁在动脉粥样硬化中的作用的最新研究进展,并讨论为什么遗传性血色素沉着症(HH)患者的动脉粥样硬化发病率没有增加的可能原因。此外,我们还分析了来自几项流行病学和动物研究的关于铁在动脉粥样形成中的作用的相互矛盾的结果。我们认为 HH 患者不会出现动脉粥样硬化,是因为动脉壁中的铁稳态(动脉粥样硬化的实际发生部位)没有受到显著影响,并支持动脉壁中的铁与动脉粥样硬化之间存在因果关系。